BMC Genetics | |
Low-frequency intermediate penetrance variants in the ROCK1 gene predispose to Tetralogy of Fallot | |
Bernard Keavney2  Deborah J Henderson2  Judith Goodship2  Caroline Relton2  Jonathan Parsons6  A Graham Stuart7  John O’Sullivan4  Frances A Bu’Lock3  Javier Granados-Riveron1  J David Brook1  Catherine Cosgrove1  Shoumo Bhattacharya5  Jamie Bentham5  Ana Topf2  Julian Palomino Doza2  | |
[1] Institute of Genetics, Nottingham University, Nottingham, UK;Institute of Genetic Medicine, Newcastle University, Newcastle, UK;University Hospitals of Leicester NHS Trust, Leicester, UK;Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK;Department of Cardiovascular Medicine, Oxford University, Oxford, UK;Leeds Teaching Hospitals NHS Trust, Leeds, UK;Bristol Royal Hospital for Children, Bristol, UK | |
关键词: Planar cell polarity pathway; Genetics; Tetralogy of fallot; Congenital heart disease; | |
Others : 1086915 DOI : 10.1186/1471-2156-14-57 |
|
received in 2012-06-13, accepted in 2013-06-05, 发布年份 2013 | |
【 摘 要 】
Background
Epidemiological studies indicate a substantial excess familial recurrence of non-syndromic Tetralogy of Fallot (TOF), implicating genetic factors that remain largely unknown. The Rho induced kinase 1 gene (ROCK1) is a key component of the planar cell polarity signalling pathway, which plays an important role in normal cardiac development. The aim of this study was to investigate the role of genetic variation in ROCK1 on the risk of TOF.
Results
ROCK1 was sequenced in a discovery cohort of 93 non-syndromic TOF probands to identify rare variants. TagSNPs were selected to capture commoner variation in ROCK1. Novel variants and TagSNPs were genotyped in a discovery cohort of 458 TOF cases and 1331 healthy controls, and positive findings were replicated in a further 209 TOF cases and 1290 healthy controls. Association between genotypes and TOF was assessed using LAMP.
A rare SNP (c.807C > T; rs56085230) discovered by sequencing was associated with TOF risk (p = 0.006) in the discovery cohort. The variant was also significantly associated with the risk of TOF in the replication cohort (p = 0.018). In the combined cohorts the odds ratio for TOF was 2.61 (95% CI 1.58-4.30); p < 0.0001. The minor allele frequency of rs56085230 in the cases was 0.02, and in the controls it was 0.007. The variant accounted for 1% of the population attributable risk (PAR) of TOF. We also found significant association with TOF for an uncommon TagSNP in ROCK1, rs288979 (OR 1.64 [95% CI 1.15-2.30]; p = 1.5x10-5). The minor allele frequency of rs288979 in the controls was 0.043, and the variant accounted for 11% of the PAR of TOF. These association signals were independent of each other, providing additional internal validation of our result.
Conclusions
Low frequency intermediate penetrance (LFIP) variants in the ROCK1 gene predispose to the risk of TOF.
【 授权许可】
2013 Palomino Doza et al.; licensee BioMed Central Ltd.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20150116020723897.pdf | 320KB | download | |
Figure 2. | 77KB | Image | download |
Figure 1. | 35KB | Image | download |
【 图 表 】
Figure 1.
Figure 2.
【 参考文献 】
- [1]Apitz C, Webb GD, Redington AN: Tetralogy of Fallot. Lancet 2009, 374(9699):1462-1471.
- [2]Burn J, Brennan P, Little J, Holloway S, Coffey R, Somerville J, Dennis NR, Allan L, Arnold R, Deanfield JE, et al.: Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 1998, 351(9099):311-316.
- [3]Boon AR, Farmer MB, Roberts DF: A family study of Fallot’s tetralogy. J Med Genet 1972, 9(2):179-192.
- [4]Goldmuntz E, Geiger E, Benson DW: NKX2.5 mutations in patients with tetralogy of fallot. Circulation 2001, 104(21):2565-2568.
- [5]Griffin HR, Topf A, Glen E, Zweier C, Stuart AG, Parsons J, Peart I, Deanfield J, O’Sullivan J, Rauch A, et al.: Systematic survey of variants in TBX1 in non-syndromic tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variants. Heart 2010, 96(20):1651-1655.
- [6]Greenway SC, Pereira AC, Lin JC, DePalma SR, Israel SJ, Mesquita SM, Ergul E, Conta JH, Korn JM, McCarroll SA, et al.: De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet 2009, 41(8):931-935.
- [7]Soemedi R, Topf A, Wilson IJ, Darlay R, Rahman T, Glen E, Hall D, Huang N, Bentham J, Bhattacharya S, et al.: Phenotype-specific effect of chromosome 1q21.1 rearrangements and GJA5 duplications in 2436 congenital heart disease patients and 6760 controls. Hum Mol Genet 2012, 21(7):1513-1520.
- [8]Goodship JA, Hall D, Topf A, Mamasoula C, Griffin H, Rahman TJ, Glen E, Tan H, Palomino Doza J, Relton CL, et al.: Common Variant in the PTPN11 Gene Contributes to the Risk of Tetralogy of Fallot. Circ Cardiovasc Genet 2012, 5(3):287-292.
- [9]Brade T, Manner J, Kuhl M: The role of Wnt signalling in cardiac development and tissue remodelling in the mature heart. Cardiovasc Res 2006, 72(2):198-209.
- [10]Henderson DJ, Phillips HM, Chaudhry B: Vang-like 2 and noncanonical Wnt signalling in outflow tract development. Trends Cardiovasc Med 2006, 16(2):38-45.
- [11]Zhao Z, Rivkees SA: Rho-associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferation. Dev Dyn 2003, 226(1):24-32.
- [12]Sakabe M, Ikeda K, Nakatani K, Kawada N, Imanaka-Yoshida K, Yoshida T, Yamagishi T, Nakajima Y: Rho kinases regulate endothelial invasion and migration during valvuloseptal endocardial cushion tissue formation. Dev Dyn 2006, 235(1):94-104.
- [13]Shimizu Y, Thumkeo D, Keel J, Ishizaki T, Oshima H, Oshima M, Noda Y, Matsumura F, Taketo MM, Narumiya S: ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles. J Cell Biol 2005, 168(6):941-953.
- [14]Ruiz-Perez VL, Blair HJ, Rodriguez-Andres ME, Blanco MJ, Wilson A, Liu YN, Miles C, Peters H, Goodship JA: Evc is a positive mediator of Ihh-regulated bone growth that localises at the base of chondrocyte cilia. Development 2007, 134(16):2903-2912.
- [15]Gaukrodger N, Mayosi BM, Imrie H, Avery P, Baker M, Connell JM, Watkins H, Farrall M, Keavney B, Connell JMC: A rare variant of the leptin gene has large effects on blood pressure and carotid intima-medial thickness: a study of 1428 individuals in 248 families. J Med Genet 2005, 42(6):474-478.
- [16]Chase DS, Tawn EJ, Parker L, Jonas P, Parker CO, Burn J: The North Cumbria Community Genetics Project. J Med Genet 1998, 35(5):413-416.
- [17]Wigginton JE, Abecasis GR: PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 2005, 21(16):3445-3447.
- [18]Li M, Boehnke M, Abecasis GR: Joint modelling of linkage and association: identifying SNPs responsible for a linkage signal. Am J Hum Genet 2005, 76(6):934-949.
- [19]Storey J: The positive palse discovery rate: A bayesian interpretation and the q-value. Ann Stat 2003, 31:2013-2035.
- [20]Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR: ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 2003, 31:3568-3571.
- [21]Nalla VK, Rogan PK: Automated splicing mutation analysis by information theory. Hum Mutat 2005, 25:334-342.
- [22]Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, Wong M, Sloan CA, Rosenbloom KR, Roe G, Rhead B, et al.: The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res 2012, 41:D64-69.
- [23]Pritchard JK, Cox NJ: The allelic architecture of human disease genes: common disease-common variant…or not? Hum Mol Genet 2002, 11(20):2417-2423.
- [24]Pritchard JK: Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001, 69(1):124-137.
- [25]Kryukov GV, Pennacchio LA, Sunyaev SR, Kryukov GV, Pennacchio LA, Sunyaev SR: Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am J Hum Genet 2007, 80(4):727-739.
- [26]Northridge ME: Public health methods–attributable risk as a link between causality and public health action. Am J Public Health 1995, 85(9):1202-1204.